Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1191 of 6351
-
Which oxygen strategy saves more lives? large trial puts three methods to the test
Disease control Stopped earlyThe goal of this clinical trial is to determine whether one of the two oxygenation or ventilation strategies (NIV and/or HFNO) is superior to standard oxygen to reduce 28-day mortality rate in hypoxemic acute respiratory failure (ARF) patients.
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Polio vaccine works alongside routine infant shots, study finds
Prevention CompletedThis study is designed to study the immunogenicity and safety of sIPV co-administered with other routine infant vaccines. According to the national immunization schedule of Bangladesh and Pakistan, sIPV was administered concomitantly with PCV10, DTP-HeB-Hib and other vaccines at …
Phase 3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Prevention
Last updated Jun 27, 2026 08:05 UTC
-
Voice box transplant trial hopes to give speech back to patients
Disease control PausedThe purpose of this proposed study is to obtain safety and efficacy data on human laryngeal allograft transplantation in an effort to safely use these procedures as a viable reconstructive option for patients with severe laryngeal or laryngotracheal incompetence.
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Zapping the heart: radiation therapy for stubborn arrhythmias
Disease control Recruiting nowVentricular tachycardia (VT) is a malignant cardiac arrhythmia subjecting our patients to a high risk of sudden death, increased morbidity and reduced quality of life. Unfortunately, failure of treatment is common and VT recurrences remain an important concern. In these patients,…
Phase 2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Sleeping in a mountain-air tent could boost weight loss, study suggests
Disease control Recruiting nowThe objective of the proposed double-blind, parallel-arm, randomized clinical trial is to evaluate changes in body weight and composition, assess determinants of energy balance (intake and expenditure), and measure modulators of energy balance, following 8 wk of calorie restricti…
Sponsor: Pennington Biomedical Research Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New migraine prevention pill tested in large chinese trial
Disease control CompletedThe purpose of this study is to learn about the effects of Rimegepant to help prevent migraine. This study is seeking for participants who: * Are male and female of 18 years of age or older. * Have at least 1 year history of migraine . * Did not take any medication for migraine…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New pill shows promise for scarred lungs in early trial
Disease control CompletedThe primary objective of this study is to evaluate the safety and tolerability of oral daily administration of TTI-101 over a 12-week treatment duration in participants with idiopathic pulmonary fibrosis (IPF).
Phase 2 • Sponsor: Tvardi Therapeutics, Incorporated • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Could a stomach balloon tame uncontrolled asthma in obese patients?
Disease control Recruiting nowThe aim of this project is to study the effect of an intragastric balloon (IGB) on asthma control in obese patients. Obese patients with uncontrolled asthma will be recruited and randomly assigned to two intervention arms : an intragastric balloon combined with diet and exercise …
Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New scan could spot prostate cancer more accurately
Diagnosis Recruiting nowThe objectives of this study are to evaluate the feasibility and safety of \[99mTc\]Tc-PSMA-T4 in the diagnosis and treatment planning of prostate cancer.
Sponsor: NCBJ Polatom: Narodowe Centrum Badań Jądrowych Polatom • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
New imaging technique could save lives after heart attacks
Disease control OngoingThe goal of this multicenter randomized clinical trial is to test the superiority in terms of efficacy of the Angiography-derived fractional flow reserve (AIR) over that based on conventional angiography (ANGIO) strategy in the management of non-culprit lesions in STEMI patients …
Sponsor: University Hospital of Ferrara • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Routine urine tests could spot bladder cancer early in smokers and factory workers
Diagnosis Recruiting nowThere is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help assess if routine screening helps finding bladder cancer at an earlier stage.
Sponsor: University of Texas Southwestern Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Robot suit could help kids with cerebral palsy walk stronger
Disease control Recruiting nowBackground: People with cerebral palsy, spina bifida, muscular dystrophy, or spinal cord injury often have muscle weakness and problems controlling how their legs move. This can affect how they walk. The NIH has designed a robotic device (exoskeleton) that can be worn on the leg…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can filtering the blood slow ALS in patients with a rogue antibody?
Disease control CompletedPatient with amyotrophic lateral sclerosis (ALS) having anti-NRIP autoantibody showed titer-dependent detrimental Effects. Plasmapheresis might benefit this subgroup of patients via removal of anti-NRIP autoantibody
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug could slow kidney failure in IgA nephropathy patients
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of Telitacicept in patients with primary IgA nephropathy at risk of progressing to end-stage renal disease(ESRD), despite maximum tolerated treatment with renin-angiotensin system(RAS) blockade using angiotensin con…
Phase 3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New imaging algorithm could spot hidden cause of chest pain without invasive procedures
Diagnosis Recruiting nowAngina is a common clinical symptom of ischemic heart disease, affecting up to 11 million people in the United States alone, and 112 million people globally. Despite this, 4 in 10 patients undergoing elective coronary angiography for angina and ischemia do not have evidence of ob…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
Could a single antibiotic be enough for cystic fibrosis lung infections?
Disease control Recruiting nowThe purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or IV). A pulmonary exacerbation is a worsening of respiratory symptoms in people wi…
Phase 4 • Sponsor: Chris Goss • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New Alzheimer's drug shows promise in early trial
Disease control CompletedThis is a multi-center, Phase IIa, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy, safety of two doses of 50561 compared to placebo in participants diagnosed with mild to moderate Alzheimer's disease.
Phase 2 • Sponsor: Beijing Joekai Biotechnology LLC • Aim: Disease control
Last updated Jun 26, 2026 18:31 UTC
-
Herbal hope: new combo therapy targets advanced pancreatic cancer
Disease control CompletedThis prospective, multicenter, randomized, double-blind, placebo-controlled phase 3 trial included adults with histologically or cytologically confirmed stage IV pancreatic ductal adenocarcinoma who were eligible for gemcitabine-based first-line combination chemotherapy according…
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New blood test could spare bile duct cancer patients unnecessary surgery
Diagnosis CompletedLymph node metastasis (LNM) is a major prognostic factor in intrahepatic cholangiocarcinoma (ICC), and accurate preoperative prediction of the presence or absence of LNM has significant clinical implications in determining treatment strategy. Despite this, there are currently no …
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Can brain scans and eye tests predict Alzheimer's years before symptoms?
Knowledge-focused Recruiting nowA regional, single-center, prospective, observational academic cohort will follow subjects who previously participated in the INSIGHT study and who agree an extension of their follow-up in the INSIGHT-2 research for additional 5-6 years. An annual multimodal evaluation (cognitive…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC